Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Noom expands its GLP-1 range with 'microdose' package Digital health company Noom has started offering lower doses of GLP-1 agonist semaglutide, the active ingredient in Novo Nordisk's weight-loss drug Wegovy, at a knock-down price
Instead, eligibility is typically determined by individual healthcare providers, often based on the same criteria used for FDA-approved versions like Ozempic or Wegovy (e.g
Mehran RJ, Walsh GL, Zalpour A, Cata JP, Correa AM, Antonoff MB , Rice DC
This was significantly better than using exenatide (56%) or metformin alone (32%)
US$ 28.49
US$ 27.01
US$ 29.93
US$ 25.31
